This compound is a quinoline derivative characterized by a cyclopropyl group and a fluorophenyl substituent. It is primarily used as an active pharmaceutical ingredient in the manufacturing of pharmaceutical products.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 121659-86-7
Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate
pharmaceutical intermediate
4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide-d5
active pharmaceutical ingredient impurity standard
Naratriptán
active pharmaceutical ingredient for migraine
Anastrozole Dimer Impurity
impurity reference standard
4,4,5,5-tetradeuterio-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
Deuterated standard for furazolidone analysis
(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol
n.a
3-(Bromomethyl)-2-cyclopropyl-4-(4-fluorophenyl)quinoline
pharmaceutical intermediate
(E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile
Pharmaceutical intermediate
methyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate
RNXQZVFWKIPEOJ-UHFFFAOYSA-N
COC(=O)C1=C(C2=CC=CC=C2N=C1C3CC3)C4=CC=C(C=C4)F
—